R
Repligen Corp D
D
RGEN
121.670
USD
-0.20
(-0.16%)
مغلق
حجم التداول
42,261
الربح لكل سهم
2
العائد الربحي
-
P/E
-290
حجم السوق
6,835,797,777
الأخبار المقالات
العنوان: Repligen Corp
القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.